Insights

YourWay Cannabis Brands Faces Challenges with Financial Reporting and Management Changes

LOS ANGELES- YourWay Cannabis Brands Inc., a company traded on the Canadian Securities Exchange  and the OTC market (OTC: YOURF), is grappling with significant challenges, including delays in financial reporting and management upheavals. The company has disclosed to its investors that it is still behind in reporting its 2022 financial results and has not yet ...

November 19th, 2023|

Maine Medical Cannabis Report Reveals High Contamination Rates

LOS ANGELES- Nearly half of the medical cannabis commercially available in Maine contains contaminants like yeast, mold, or pesticides, a new report from the state's Office of Cannabis Policy (OCP) reveals. The findings, detailed in a 49-page summary, show that out of 120 medical cannabis samples, 50 failed the safety testing standards set for recreational ...

November 19th, 2023|

British American Tobacco Amplifies Investment in Organigram

LOS ANGELES- British American Tobacco (BAT), a global tobacco company, has significantly increased its investment in Canadian cannabis producer Organigram Holdings. The latest investment of 124.6 million Canadian dollars ($92.5 million) marks a deepening partnership between the two companies, following BAT's previous investments of CA$6.35 million in 2022 and an initial CA$220 million in 2021. ...

November 16th, 2023|

Maryland Launches Social Equity-Focused Adult-Use Cannabis Licensing

LOS ANGELES- Maryland has officially opened the first round of its adult-use cannabis licensing process, marking a significant step forward in the state's cannabis industry. In a move to promote social equity, this initial phase exclusively reserves licenses for social equity applicants, a decision aligned with state law mandates. Defined by state legislation, social equity ...

November 16th, 2023|

AI in Cannabis Cultivation: Navigating the Future of Efficiency and Craftsmanship

NEW YORK– The cannabis industry, long characterized by its blend of traditional cultivation methods and pioneering spirit, is now on the verge of a technological transformation. The integration of Artificial Intelligence (AI) into cannabis production heralds a new era where efficiency, quality, and innovation converge. Automating Cultivation: The AI Edge At the heart of this ...

November 15th, 2023|

FDA Submission of MDMA-Assisted Therapy Application Aims to Advance Mental Health Landscape

  NEW YORK- In a landmark move, MAPS Public Benefit Corporation (MAPS PBC), a subsidiary of the notable Multidisciplinary Association for Psychedelic Studies (MAPS), has officially lodged a new drug application with the U.S. Food and Drug Administration (FDA) for MDMA-assisted therapy, potentially revolutionizing treatment for Post-Traumatic Stress Disorder (PTSD). This submission, the culmination of ...

December 14th, 2023|

Massachusetts Governor Introduces Veteran-Focused Legislation Including Psychedelic Research

BOSTON — In a landmark move, Massachusetts Governor Maura T. Healey has filed a comprehensive legislative package aimed at enhancing benefits and services for the state's military veterans. Dubbed the Act Honoring, Empowering and Recognizing Our Servicemembers and Veterans (HERO Act), the bill was introduced with Lieutenant Governor Kim Driscoll at the Massachusetts Executive Office of ...

November 14th, 2023|

Red Light Holland’s Psilocybin Capsules Prove Stable in Extended Testing, Eyeing Global Markets

LOS ANGELES- Red Light Holland Corp., has announced significant advancements in their natural psilocybin microdosing capsules. Developed from psilocybin truffles grown on the company’s farm in the Netherlands, these capsules have successfully passed a four-month stability test, confirming the stability of psilocybin. This recent accomplishment builds on the company's prior achievements, including the completion of ...

November 14th, 2023|

Navigating Co-Investments in the Cannabis Industry: A Strategic Guide for Family Offices

NEW YORK-Family offices operating in the cannabis industry often view co-investing as a pivotal component of their investment strategy. When executed thoughtfully, these collaborations not only spread the risk associated with cannabis investments but also present opportunities for substantial returns, introductions to new segments of the industry, and effective risk mitigation. For Chief Investment Officers ...

November 13th, 2023|

National Psychedelics Reform Movement Gains Momentum Across the U.S.

LOS ANGELES- The movement for psychedelics reform in the United States is gaining significant traction, with numerous states considering decriminalization, legalization, or rescheduling proposals, as well as other measures to facilitate access to new therapies. In California, the TREAT initiative, aimed at creating a state agency to fund and promote psychedelics research, was withdrawn from ...

November 13th, 2023|

Optimi Health Corp. Successfully Resolves Supply Agreement Dispute

LOS ANGELES- Optimi Health Corp. a key player in the psychedelics sector, recently announced the amicable resolution of a dispute regarding the termination of a supply agreement with a private entity, initially signed on May 4, 2023. This development marks a significant stride in the company's efforts to maintain harmonious and professional relationships with its ...

November 12th, 2023|
  • CanPay

Navigating the Cannabis Landscape: A Comprehensive Guide to Due Diligence for Investors

NEW YORK- The cannabis industry's unprecedented growth trajectory has positioned it as a lucrative investment landscape. However, the nascent nature of the sector, coupled with regulatory intricacies and market uncertainties, underscores the critical importance of rigorous due diligence for prospective investors. In this comprehensive guide, we delve into the intricate steps necessary to conduct thorough ...

November 11th, 2023|

Vermont Halts New Large-Scale Cannabis Grower Licenses to Support Smaller Farms Amid Tough Agricultural Year

LOS ANGELES- In a strategic move to bolster smaller local cultivators, Vermont has announced a temporary suspension of issuing new licenses for large-scale cannabis growers. This decision was disclosed on Tuesday by state officials, marking a significant step in Vermont’s efforts to balance its burgeoning legal cannabis market. James Pepper, the chairman of Vermont’s Cannabis ...

November 10th, 2023|

PharmAla Biotech Breaks New Ground with Psychedelic Substance Shipment to Australia

LOS ANGELES- The recent dispatch of MDMA and psilocybin from Canadian-based PharmAla Biotech to its Australian joint venture, Cortexa, marks a pivotal progression in the emerging domain of psychedelic-assisted therapies. This venture not only underscores a burgeoning global curiosity in these substances as possible remedies for a range of mental health ailments but also underscores ...

November 8th, 2023|

Ohio Joins the Green Wave with Legalization of Adult-Use Cannabis

In a historic move mirroring a national shift, Ohio voters have chosen to greenlight the legalization of adult-use cannabis, making it the latest state to adopt a more progressive stance on the once controversial substance. The passage of Issue 2 during the recent election, with a 56.97% majority, signals a remarkable change in attitude since ...

November 8th, 2023|

Cybin’s Clinical Trial Indicates Promising Results for Psychedelic Mental Health Treatment

A Canadian biopharmaceutical firm, Cybin, has shared promising results from a clinical trial suggesting the potential of psychedelic compounds in treating mental health issues. The company's focus on developing advanced psychedelic therapeutics has yielded a significant milestone with their proprietary compound, CYB003. CYB003 Demonstrates Significant Reduction in Depression Symptoms Cybin's recent press release detailed the ...

November 6th, 2023|

U.S. States Navigate Psychedelics Reforms Amidst Legalization Efforts

As the United States continues to explore the boundaries of drug policy reform, numerous state legislatures and advocacy groups are engaging in a concerted effort to redefine the legal status of psychedelics. From decriminalization and legalization to the establishment of new research agencies, the landscape of psychedelics law is shifting, albeit with nuanced public support. ...

November 6th, 2023|

Alabama Medical Cannabis Commission Sets December Goal for Licensing Amid Legal Challenges

Alabama — After navigating through a series of legal hurdles and procedural delays, the Alabama Medical Cannabis Commission (AMCC) is now targeting December to finalize industry licenses, a move that its chairman describes as part of an "aggressive" timeline. This latest development comes as the commission attempts to recover from a summer marked by regulatory ...

November 5th, 2023|

Kansas City Cannabis Workers Vote to Unionize, Joining Teamsters Local 955

LOS ANGELES— Employees at Home State Dispensary in Kansas City have made a landmark decision to unionize, becoming the first group of cannabis workers in the metro area to do so. The budtenders and inventory clerks have elected to join Teamsters Local 955, marking a significant moment for labor relations within Missouri's burgeoning cannabis industry. ...

November 5th, 2023|

MindMed Projects Operational Continuity into 2026 Amid Advancements in LSD-Based Anxiety Treatment

NEW YORK — Mind Medicine Inc. (MindMed), a biopharmaceutical company leading the charge in psychedelic drug development, has assured stakeholders of its financial viability well into 2026. This assurance comes even as the company, which currently does not generate revenue, moves closer to the potential market introduction of its proprietary LSD formulation intended for anxiety treatment. ...

November 5th, 2023|

Psyence Group Advances Psilocybin Production with Facility Expansion and Strategic Partnerships

LOS ANGELES- Psyence Group Inc.  a trailblazer in the clinical-stage life sciences sector specializing in nature-derived psilocybin for mental health treatments, has announced significant developments in its Psyence Production division. The company takes pride in operating one of the pioneering government-licensed commercial psilocybin cultivation facilities, located in Southern Africa and ISO22000 certified, which positions Psyence ...

November 3rd, 2023|

U.S. Cannabis Operators Challenge Federal Enforcement in Landmark Lawsuit

LOS ANGELES- In a bold move that underscores the growing tension between state legislation and federal restrictions, a coalition of U.S. cannabis operators and investors has filed a lawsuit challenging the federal government's application of the Controlled Substances Act (CSA) to cannabis. The suit claims that the federal prohibition of cannabis stands in stark conflict ...

November 3rd, 2023|

Navigating Cannabis Conferences: A Comprehensive Guide for Companies

LOS ANGELES--If your company is gearing up to attend a cannabis conference, it's crucial to approach it with a well-thought-out strategy. The earlier you start your preparations, the better the results you can expect. My team and I started this SOP for MJBizCon, and I wanted to share it with any other teams planning to ...

November 3rd, 2023|
Go to Top